Pfizer M & A M & A is set to be the largest merger case in the pharmaceutical industry in 10 years
Release time: 2009-09-17 & nbsp & nbsp & nbsp Source:
On the evening of July 20，Global Medicine Producer WyetH Company Wyeth Co., Ltd.，Voting with an overwhelming majority，Passing the company by the industry giant Pfizer (PFIZER) resolution with a total value of $ 68 billion.
This is also the largest amount of super mergers and acquisitions in the 10 years of the pharmaceutical stake sports betting appStake Sports Bettingindustry。Through this merger，Pfizer-Wyeth will consolidate the status of "the world's largest pharmaceutical company"，far surpassed GlaxoSmotesk、Bayer、Roche and other giants。Chairman and CEO of Pfizer Jeffrey Gilller previously said: "Pfizer and Wyeth merged，It provides an excellent opportunity for industrial transformation，The world's largest biopharmaceutical company，It will be unique、Diverse and large -scale advantages stand in the global medical market。”
This is also the largest amount of super mergers and acquisitions in the 10 years of the pharmaceutical stake sports betting appStake Sports Bettingindustry。Through this merger，Pfizer-Wyeth will consolidate the status of "the world's largest pharmaceutical company"，far surpassed GlaxoSmotesk、Bayer、Roche and other giants。Chairman and CEO of Pfizer Jeffrey Gilller previously said: "Pfizer and Wyeth merged，It provides an excellent opportunity for industrial transformation，The world's largest biopharmaceutical company，It will be unique、Diverse and large -scale advantages stand in the global medical market。”
